The Fleischner Society meets The Netherlands
For the first time in three years, the Fleischner Society will have an on-site meeting. World renowned specialists of multiple disciplines are gathering in Amsterdam to discuss most recent scientific developments for diagnosis and treatment of thoracic diseases..png "Check the full invitation")
Program
| 09.30 - 10.00 | Pathology and Radiology: what do they learn from each other? Prof. J Galvin and Prof. T. Franks |
| 10.00 - 10.30 | Interstitial lung abnormalities: what are they and what do they mean? Dr. C. Ryerson and N. Sverzellati, PhD |
| 10.30 - 11.00 | Progressive phenotype of interstitial fibrosis: definition, diagnosis and treatment Dr. K. Brown and Dr. D. Lynch |
| 11.00 - 11.15 | Questions and Answers |
| 11.15 - 11.45 | Coffee break |
| 11.15 - 13.00 | Clinical Case Discussion: Dr. M. Wijsenbeek and Prof. J. Grutters |
| 13.00 - 14.00 | Lunch break |
| 14.00 - 14.30 | Drug induced lung disease in Oncology: diagnosis and treatment Dr. C. Powell and Prof. C. Schaefer-Prokop |
| 14.30 - 15.00 | Sarcoidosis: different phenotypes and treatment Prof. A. Wells and Prof. S. Desai |
| 15.00 - 15.15 | Questions and Answers |
| 15.15 - 15.45 | Coffee break |
| 15.45 - 17.00 | Clinical Case discussion Dr. M. Veltkamp and Dr. W. van Es |
| 17.00 | Wrap up and drinks |
Invitation
The Fleischner Society meets “The Netherlands”
June 25th Amsterdam
On behalf of the President of the Fleischner Society in 2022 Cornelia Schaefer-Prokop, it is our pleasure to invite Dutch pulmonologists and radiologists to this one day symposium to discuss diagnostic and therapeutic concepts of Interstitial Lung Diseases.
The program will cover progressive fibrotic phenotype and interstitial lung abnormalities, phenotypes of sarcoidosis, pulmonary hypertension in interstitial lung disease and drug induced interstitial lung disease.
Authors of the Fleischner Society and leading expert in this field, will present their positioning regarding this topics. Among others, David Lynch, Luca Richeldi, Athol Wells, Sujal Desai or Nicola Sverzerlatti.
Dutch experts from the various centers - among them Jan Grutters, Marlies Wijsenbeek, Wouter van Es, Esther Nossent en Pim de Jong – will present illustrative and challenging cases to foster an interesting and instructive discussion with experts and auditorium.
You can register by e-mailing to Pascale van Hamersveld via PY.van.hamersveld@meandermc.nl
We are looking forward to meeting you in Amsterdam.
With kind regards,
Boehringer Ingelheim, Siemens and Canon, jointly on behalf of the President of the Fleischner Society, Cornelia Schaefer-Prokop
Practical information:
- Costs: €75 for specialists and €50 for residents
- Accreditation: Accreditation is requested from NVALT and NVvR
- Location: Felix Meritis, Keizersgracht 324, 1016 EZ, Amsterdam
CGR Code of Conduct
Boehringer Ingelheim adheres to the Code of Conduct for Medicinal Advertising of the Foundation of the CGR (hereinafter: the CGR Code of Conduct), including the provisions on transparency registers and the participation of partners (www.cgr.nl).
This symposium is sponsored by Boehringer Ingelheim. Your data, name, address, profession, email address and license number (BIG), will be shared with Boehringer Ingelheim. For more information on data protection, Boehringer Ingelheim privacy statement.